Free Trial
NASDAQ:APDN

Applied DNA Sciences (APDN) Stock Price, News & Analysis

Applied DNA Sciences logo
$2.86 -0.02 (-0.69%)
As of 10:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Applied DNA Sciences Stock (NASDAQ:APDN)

Advanced

Key Stats

Today's Range
$2.84
$2.90
50-Day Range
$2.32
$5.34
52-Week Range
$2.13
$1,064.85
Volume
9,526 shs
Average Volume
112,111 shs
Market Capitalization
$3.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Applied DNA Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

APDN MarketRank™: 

Applied DNA Sciences scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Applied DNA Sciences.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Applied DNA Sciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Applied DNA Sciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Applied DNA Sciences has a P/B Ratio of 0.01. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    8.41% of the float of Applied DNA Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Applied DNA Sciences has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Applied DNA Sciences has recently increased by 62.18%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Applied DNA Sciences does not currently pay a dividend.

  • Dividend Growth

    Applied DNA Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.41% of the float of Applied DNA Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Applied DNA Sciences has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Applied DNA Sciences has recently increased by 62.18%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Applied DNA Sciences has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Industrials companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Applied DNA Sciences this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.17% of the stock of Applied DNA Sciences is held by insiders.

  • Percentage Held by Institutions

    Only 22.22% of the stock of Applied DNA Sciences is held by institutions.

  • Read more about Applied DNA Sciences' insider trading history.
Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APDN Stock News Headlines

Earnings Scheduled For August 26, 2025
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
Applied DNA Sciences Focuses on LineaRx for Growth
Applied DNA Sciences Regains Nasdaq Compliance
Applied DNA Sciences, Inc. (APDN) - Yahoo Finance
APDN - Applied DNA Sciences Inc News - Morningstar
See More Headlines

APDN Stock Analysis - Frequently Asked Questions

Applied DNA Sciences' stock was trading at $153.00 at the beginning of the year. Since then, APDN stock has decreased by 98.1% and is now trading at $2.88.

Applied DNA Sciences Inc (NASDAQ:APDN) issued its quarterly earnings results on Thursday, August, 14th. The technology company reported ($34.00) earnings per share (EPS) for the quarter, topping the consensus estimate of ($37.50) by $3.50. The technology company had revenue of $0.30 million for the quarter, compared to analysts' expectations of $1.28 million. Applied DNA Sciences had a negative net margin of 399.91% and a negative trailing twelve-month return on equity of 136.17%.

Shares of Applied DNA Sciences reverse split before market open on Sunday, June 1st 2025.The 1-15 reverse split was announced on Sunday, June 1st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, June 1st 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Applied DNA Sciences investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), Virgin Galactic (SPCE), AST SpaceMobile (ASTS) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
8/14/2025
Today
9/17/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
PROTECTION - SFTY
Sub-Industry
Business Services
Current Symbol
NASDAQ:APDN
CIK
744452
Employees
70
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($923.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.99 million
Net Margins
-399.91%
Pretax Margin
-394.30%
Return on Equity
-136.17%
Return on Assets
-101.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.76
Quick Ratio
2.60

Sales & Book Value

Annual Sales
$3.43 million
Price / Sales
1.08
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$215.25 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
1,290,000
Free Float
1,289,000
Market Cap
$3.70 million
Optionable
Optionable
Beta
0.09

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:APDN) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners